Table of Contents
Research & Development
| Merck & Co. Inks US$2.2 B IBD Target Discovery Collaboration with Quotient Therapeutics | Abstract pdf html |
| Hitesh Udar |
Mergers & Acquisitions
| Lilly Pays US$2.4 B to Acquire Orna Therapeutics and its CAR-T Cell Therapies for Autoimmune Diseases | Abstract pdf html |
| Naini Anand |
| Merck & Co. Expands Haematology Portfolio with US$6.7 B Acquisition of Terns Pharmaceuticals | Abstract pdf html |
| Nikita Negi |
Opinion & Analysis
| IQVIA Pharma Deals Review of 2025 | Abstract pdf |
| Lucy Haggerty,Taskin Ahmed, Ayush Saxena & Shikha Kashyap |
This work is licensed under a Creative Commons Attribution 3.0 License.